Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects.
Atherosclerosis
; 231(2): 411-20, 2013 Dec.
Article
em En
| MEDLINE
| ID: mdl-24267260
Palavras-chave
ACE; ACS; ALT; ARB; AST; BP; CHD; CIMT; CRP; Dyslipidemia; Ezetimibe; HDL; IL; Inflammation; LDL; Microarray; Mononuclear cells; NFk-B; PBMCs; Platelet adhesion; ROS; Statin; TC; TNF; TRG; Thrombosis; VWF; acute coronary syndrome; alanine aminotransferase; angiotensin receptor blockers; angiotensin-converting enzyme; aspartate aminotransferase; blood pressure; c-reactive protein; carotid intima-media thickness; coronary heart disease; high-density lipoprotein cholesterol; interleukin; low-density lipoprotein cholesterol; nuclear factor kappaB; peripheral blood mononuclear cells; reactive oxygen species; total cholesterol; triglyceride; tumor necrosis factor; von Willebrand factor
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Azetidinas
/
Regulação da Expressão Gênica
/
Sinvastatina
/
Hipercolesterolemia
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prevalence_studies
/
Qualitative_research
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Atherosclerosis
Ano de publicação:
2013
Tipo de documento:
Article